Pioneering Medical Innovations
Boston Scientific (NYSE:BSX) said today it inked a deal worth up to $300 million to acquire Apama Medical and its radiofrequency balloon catheter system designed to treat atrial fibrillation.
Boston Scientific (NYSE:BSX) said today it inked a deal worth up to $300 million to acquire Apama Medical and its radiofrequency balloon catheter system designed to treat atrial fibrillation.
CAMPBELL, Calif., Jan. 13, 2015 /PRNewswire/ — Apama Medical, Inc., a privately held medical device company focused on the development of